Creative Planning raised its position in The Pennant Group, Inc. (NASDAQ:PNTG – Free Report) by 2.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,152 shares of the company’s stock after purchasing an additional 373 shares during the quarter. Creative Planning owned 0.06% of The Pennant Group worth $444,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the company. Covestor Ltd boosted its holdings in The Pennant Group by 3,805.6% in the 1st quarter. Covestor Ltd now owns 1,406 shares of the company’s stock worth $28,000 after acquiring an additional 1,370 shares during the period. Principal Financial Group Inc. bought a new stake in shares of The Pennant Group in the first quarter worth $197,000. Acadian Asset Management LLC acquired a new stake in The Pennant Group in the first quarter valued at $218,000. Bailard Inc. bought a new position in The Pennant Group during the 2nd quarter valued at $253,000. Finally, The Manufacturers Life Insurance Company grew its holdings in The Pennant Group by 4.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,227 shares of the company’s stock worth $260,000 after acquiring an additional 471 shares in the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.
The Pennant Group Trading Up 0.6 %
The Pennant Group stock opened at $35.01 on Wednesday. The Pennant Group, Inc. has a 12-month low of $10.46 and a 12-month high of $37.13. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.12 and a quick ratio of 1.12. The stock has a market capitalization of $1.05 billion, a PE ratio of 64.83, a price-to-earnings-growth ratio of 3.48 and a beta of 2.01. The firm has a 50 day simple moving average of $33.30 and a 200-day simple moving average of $26.91.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on PNTG shares. Stephens restated an “overweight” rating and issued a $40.00 target price on shares of The Pennant Group in a research note on Wednesday, October 9th. Truist Financial lifted their price target on shares of The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a report on Monday, October 7th. Finally, Oppenheimer raised their target price on The Pennant Group from $28.00 to $34.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th.
Read Our Latest Stock Report on PNTG
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Read More
- Five stocks we like better than The Pennant Group
- Investing In Preferred Stock vs. Common Stock
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.